Search research articles
Contact Us
Filters
Showing results (11-20 of 38) with videos related to
Page
of 4
Sort By:
Bioconjugate Chemistry
|
November 1, 2011
Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice
Holly R Davison, Stephanie Taylor, Chris Drake, et al.
Arthritis and Rheumatism
|
May 28, 2010
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system
Reinhard Meier, Christian Krug, Daniel Golovko, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 24, 2016
Variability and bias assessment in breast ADC measurement across multiple systems
Kathryn E Keenan, Adele P Peskin, Lisa J Wilmes, et al.
Tomography (Ann Arbor, Mich.)
|
January 28, 2017
Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) Survey
Brenda F Kurland, Sameer Aggarwal, Thomas E Yankeelov, et al.
Scientific Reports
|
December 15, 2020
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
Deep K Hathi, Wen Li, Youngho Seo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer
Suzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 8, 2016
Design of a breast phantom for quantitative MRI
Kathryn E Keenan, Lisa J Wilmes, Sheye O Aliu, et al.
Cancers
|
June 13, 2020
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
Ella F Jones, Deep K Hathi, Rita Freimanis, et al.
Nuclear Medicine and Biology
|
July 15, 2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
Tanushree Ganguly, Shorouk Dannoon, Mark R Hopkins, et al.
Journal of Breast Imaging
|
August 18, 2020
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients
Vignesh A Arasu, Paul Kim, Wen Li, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 38) with videos related to
Sort By:
Page
of 4
Bioconjugate Chemistry
|
November 1, 2011
Functional fluorescently labeled bithiazole ΔF508-CFTR corrector imaged in whole body slices in mice
Holly R Davison, Stephanie Taylor, Chris Drake, et al.
Arthritis and Rheumatism
|
May 28, 2010
Indocyanine green-enhanced imaging of antigen-induced arthritis with an integrated optical imaging/radiography system
Reinhard Meier, Christian Krug, Daniel Golovko, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 24, 2016
Variability and bias assessment in breast ADC measurement across multiple systems
Kathryn E Keenan, Adele P Peskin, Lisa J Wilmes, et al.
Tomography (Ann Arbor, Mich.)
|
January 28, 2017
Accrual Patterns for Clinical Studies Involving Quantitative Imaging: Results of an NCI Quantitative Imaging Network (QIN) Survey
Brenda F Kurland, Sameer Aggarwal, Thomas E Yankeelov, et al.
Scientific Reports
|
December 15, 2020
Evaluation of primary breast cancers using dedicated breast PET and whole-body PET
Deep K Hathi, Wen Li, Youngho Seo, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 14, 2009
Assessment of an 18F-labeled phosphoramidate peptidomimetic as a new prostate-specific membrane antigen-targeted imaging agent for prostate cancer
Suzanne E Lapi, Hilla Wahnishe, David Pham, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
March 8, 2016
Design of a breast phantom for quantitative MRI
Kathryn E Keenan, Lisa J Wilmes, Sheye O Aliu, et al.
Cancers
|
June 13, 2020
Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy
Ella F Jones, Deep K Hathi, Rita Freimanis, et al.
Nuclear Medicine and Biology
|
July 15, 2015
A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
Tanushree Ganguly, Shorouk Dannoon, Mark R Hopkins, et al.
Journal of Breast Imaging
|
August 18, 2020
Predictive Value of Breast MRI Background Parenchymal Enhancement for Neoadjuvant Treatment Response among HER2- Patients
Vignesh A Arasu, Paul Kim, Wen Li, et al.
Page
of 4